Lexicon Pharmaceuticals, Inc. Announces Closing of Public Offering and Concurrent Private Placement
Vinson & Elkins advised Lexicon Pharmaceuticals, Inc. (the “Company”) in the completion of a public offering and concurrent private placement of shares of its common stock.
After giving effect to the full exercise by the underwriters and the private placement purchaser of their respective options to purchase additional shares, the Company sold a total of approximately 55.3 million shares for total gross proceeds of approximately $143.8 million, before deducting underwriting discounts and commissions and other offering expenses.
The Vinson & Elkins team was led by partners David Oelman and Jackson O’Maley, with assistance from associates Chandler Spinks, John Frey and Alex Riddle. Also advising were partner David D’Alessandro and counsel Missy Spohn; and counsel Rajesh Patel.
About Vinson & Elkins
For more than a century, Vinson & Elkins has provided outstanding client service across important industries that drive the global economy. Built on a strong culture of collaboration across 11 offices worldwide, V&E lawyers are committed to excellence, offering clients decades of legal experience in handling transactions, investments, projects and disputes across the globe. Learn more by visiting www.velaw.com or connect with us on LinkedIn.
For more information, please speak with our media contacts.